EUVIMEDEUVIMED entdecken
Crossref

Equine Doping Controls of Thymosin β4: A Population Study and Strategy for Misuse Detection

Vivian Delcourt iD, Patrice Garcia iD, Benjamin Chabot, Nina Aber, Mylène Pescher, Marie Cacault, Priscilla Scholtes, Benoit Loup iD, Agnès Barnabé iD, Marie-Agnès Popot iD, Ludovic Bailly-Chouriberry iD

Drug Testing and Analysis · 2025-07 · 17 (7) · 1071-1077

DOI: 10.1002/dta.3806 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Testing and Analysis, online erschienen am 24.09.2024. Verfasst von Vivian Delcourt und 10 weiteren Autor:innen. Beteiligte Einrichtung: GIE LCH, Laboratoire des Courses Hippiques, Verrières-le-Buisson, France. Hauptthemen laut MEDLINE: Doping in Sports, Thymosin, Substance Abuse Detection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Institut Français du Cheval et de l'Equitation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thymosin 4 (TB4) is a ubiquitous, highly conserved and abundant peptide among mammals with a critical role in cytoskeleton organization. In spite of its yet non‐authorized use as a medicine and being forbidden by the IFHA, the FEI, and the WADA, intelligence and doping control laboratories reported numerous products available online claiming to contain a synthetic acetylated fragment of TB4 or TB4 itself, promoted as a growth factor with regenerative properties. In this article, the first estimation of the endogenous TB4 concentration in racing horses’ blood samples was performed through a population study. We reveal that this concentration does not significantly depend on gender, age, nor horse breed. We highlight that the TB4 concentration increases significantly and rapidly in plasma stored at 4°C when not separated from blood cells due to cell lysis. Finally, we also demonstrate that the detection of a non‐natural synthesis impurity is possible in equine plasma after a single dose administration of a TB4 containing product to a horse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Doping in SportsThymosinSubstance Abuse DetectionHorsesAnimalsMaleFemaleThymosin beta(4)

Stichwörter der Autor:innen

endogenous compoundequine doping controlspopulation studythymosin β 4

Substanzen

ThymosinThymosin beta(4)

Autor:innen und Institutionen

  • GIE LCH, Laboratoire des Courses Hippiques, Verrières-le-Buisson, France.

ORCID-Profile: Vivian Delcourt, Patrice Garcia, Benoit Loup, Agnès Barnabé, Marie-Agnès Popot, Ludovic Bailly-Chouriberry

Förderung

  • Institut Français du Cheval et de l'Equitation

Zitieren

APA

Delcourt, V., Garcia, P., Chabot, B., Aber, N., Pescher, M., Cacault, M., Scholtes, P., Loup, B., Barnabé, A., Popot, M. A., & Bailly-Chouriberry, L. (2025). Equine Doping Controls of Thymosin β4: A Population Study and Strategy for Misuse Detection. Drug Testing and Analysis, 17(7), 1071-1077. https://doi.org/10.1002/dta.3806

Vancouver

Delcourt V, Garcia P, Chabot B, Aber N, Pescher M, Cacault M, et al. Equine Doping Controls of Thymosin β4: A Population Study and Strategy for Misuse Detection. Drug Testing and Analysis. 2025;17(7):1071-1077. doi:10.1002/dta.3806

BibTeX
@article{Delcourt2025,
  author = {Delcourt, Vivian and Garcia, Patrice and Chabot, Benjamin and Aber, Nina and Pescher, Mylène and Cacault, Marie and Scholtes, Priscilla and Loup, Benoit and Barnabé, Agnès and Popot, Marie-Agnès and Bailly-Chouriberry, Ludovic},
  title = {Equine Doping Controls of Thymosin β4: A Population Study and Strategy for Misuse Detection},
  journal = {Drug Testing and Analysis},
  year = {2025},
  volume = {17},
  number = {7},
  pages = {1071--1077},
  doi = {10.1002/dta.3806}
}
Kostenlos starten →